Beauty In Five

The daily five-minute brief on the beauty business.

Daily brief · 5 min
0:00 / 4:42

The day's stories

01

L'Oréal's Innovist stake purchase faces Australian review

L'Oréal's proposed majority stake in India's Innovist is under Australian regulatory review, a clearance step that could affect deal timing.

L'Oréal's proposal to acquire 65.22 percent of Onesto Labs, which trades as Innovist, is facing a regulatory review in Australia, according to MLex. The cosmetics maker disclosed the transaction in a statement, per the report. MLex reports the Australian review adds a clearance step that could shape the timing of the acquisition. Details of the review's scope and expected timeline were not specified in the summary.

02

California designates nail product as priority under chemical program

California's DTSC has flagged nail products high in triphenyl phosphate as a priority product, a step that could prompt reformulation or reporting obligations.

Full story

The California Department of Toxic Substances Control has designated nail products containing more than 250 parts per million of triphenyl phosphate as a priority product under its Safer Consumer Products Program, according to Global Cosmetics News. The report indicates the move also expands chemical restrictions covering cleaning products. A priority-product designation may require affected formulators to evaluate alternatives or meet reporting obligations, though the summary does not detail compliance deadlines. The full scope of the requirements was not specified.

03

Sephora names 2026 Accelerate cohort of emerging brands

Sephora has revealed its 2026 Accelerate cohort, a program offering emerging brands mentorship, grants and investor connections.

Full story

Sephora has revealed the emerging brands selected for its 2026 Accelerate program, according to Cosmetics Business and Fashionista. The reports describe a six-month curriculum featuring mentorship, merchandising support, grants and investor connections for participating brands. The selection signals which emerging companies gain access to the retailer's development pathways. The named participants were not detailed in the summary.

04

Amorepacific plans sale of inner-beauty manufacturing plant

Amorepacific is seeking to sell its Anseong supplement plant, a move it frames as improving capital efficiency to refocus on core beauty.

Full story

Amorepacific is seeking to sell its Anseong health supplement manufacturing plant as part of a broader restructuring, according to Global Cosmetics News. The company frames the divestment as a step to improve capital efficiency and strengthen its core beauty and inner-beauty businesses, per the report. Terms of the potential sale, including a buyer or price, were not specified in the summary.

Also moving today

Read the transcript
Welcome in, today is Thursday, July twenty-third, and we begin with L'Oréal, whose move for a majority stake in an Indian beauty maker has drawn a fresh regulatory look in Australia. The proposal on the table is for L'Oréal to acquire just over sixty-five percent of Onesto Labs, the company that trades as Innovist. It now sits with the Australian Competition and Consumer Commission. In a statement Wednesday, the regulator opened the deal to public feedback through July twenty-ninth, a clearance step that could shape the timing of L'Oréal's stated push for control, according to MLex. The watchdog noted that L'Oréal sells haircare, skincare, makeup and fragrance across Australian pharmacies, supermarkets and its own stores, while Innovist reaches shoppers directly through its Bare Anatomy and Chemist at Play brands. Industry reaction leans toward reading the move as a marker that India's direct-to-consumer beauty sector has matured to acquisition scale, with global players chasing digital-native Gen Z and Millennial consumers. Also today, regulators in California are tightening chemical rules that reach into the nail category. The state's Department of Toxic Substances Control has designated nail products containing more than two hundred and fifty parts per million of triphenyl phosphate, a common plasticizer, as a priority product under its Safer Consumer Products Program, according to Global Cosmetics News. That label is the trigger that can push brands toward reformulation or new reporting on the ingredient. In the same action, the department proposed banning cleaning products made with hydrofluoric acid. For nail formulators, the priority-product tag reads as an early signal to review supplier inputs before the obligations firm up. Separately, Sephora has named the brands for the tenth class of its Accelerate program. Twelve emerging founders across skincare, makeup, haircare and fragrance join a six-month curriculum that pairs mentorship and merchandising support with grants and investor connections, according to Fashionista and Cosmetics Business. Participants also gain a place at Sephora's Impact Summit and can apply for a one-hundred-thousand-dollar grant awarded with the Fifteen Percent Pledge. For an early-stage brand, that mix of a major retailer's shelf expertise and capital access is the kind of runway that can decide which independents scale and which stall. This year's cohort includes names such as Forta Cosmetics, Mowe Beauty and Pepper Pout. Also today, Amorepacific is looking to sell a factory. The Korean beauty group is seeking a buyer for its Anseong plant, which makes the ingestible health supplements behind its inner-beauty line, as part of a broader restructuring, according to Global Cosmetics News. The company frames the sale as a capital-efficiency move, one meant to free resources to strengthen its core beauty and inner-beauty businesses rather than a retreat from the supplements category. Selling the manufacturing while keeping the brand is a familiar asset-light play, shifting production off the balance sheet to concentrate spending where the group expects growth. Now, a few more headlines moving the trade today. Kylie Cosmetics is teasing Mood Stone, a new three-scent fragrance franchise that builds on its Cosmic collection, per Cosmetics Business. Building on our earlier coverage of AI beauty visibility, an Avenue Z report finds earned media, not brands' own content, shapes what ChatGPT surfaces, with La Roche-Posay, CeraVe and Olaplex ranking highest. Givaudan plans to take a stake in Swiss start-up Microcaps to bolster its fragrance micro-encapsulation, the technology that helps scent last longer, according to Premium Beauty News. MCoBeauty is reviving its original All Nighter setting spray with maker Skindinavia as the All Dayer, at a lower price, after ending production with Urban Decay, per Cosmetics Business. And in an opinion piece for Cosmetics Business, consultant Hannah Belsham argues experiential events, from Sephora's Sephoria to Olive Young's US party push, are becoming retailers' favored tactic for cracking new markets. And finally, WWD reports the death of Allan Mottus, the longtime beauty editor and consultant known for his hard questions and long influence on the industry, at eighty-one.